China’s obesity drug makers take on global giants as Novo Nordisk patent expires
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-03-26 14:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, Economy & Finance, China, Financial Markets, Drugs, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market
--------------------------------------------------------------------